Radioimmunotherapy targeting the extra domain B of fibronectin in C6 rat gliomas: a preliminary study about the therapeutic efficacy of iodine-131-labeled SIP(L19)

This publication has 30 references indexed in Scilit:

• Tumour vascular targeting
  Nature Reviews Cancer, 2005
• Intralesional radioimmunotherapy in the treatment of malignant glioma: clinical and experimental findings
  Published by Springer Nature ,2003
• Phase II Trial of Murine ¹³¹I-Labeled Antitenascin Monoclonal Antibody 81C6 Administered Into Surgically Created Resection Cavities of Patients With Newly Diagnosed Malignant Gliomas
  Journal of Clinical Oncology, 2002
• Initial experience with locoregional radioimmunotherapy using 131I-labelled monoclonal antibodies against tenascin (BC-4) for treatment of glioma (WHO III and IV)
  Nuklearmedizin-Nuclear Medicine, 2002
• Brain Tumors
  New England Journal of Medicine, 2001
• Role of nuclear medicine in the treatment of malignant gliomas: the locoregional radioimmunotherapy approach
  European Journal of Nuclear Medicine and Molecular Imaging, 2000
• Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin
  European Journal of Nuclear Medicine and Molecular Imaging, 1999
• Hypofractionated stereotactic radiotherapy in the management of recurrent glioma
  International Journal of Radiation Oncology*Biology*Physics, 1997
• Assumptions in the radiotherapy of glioblastoma
  Neurology, 1980
• Tumor Angiogenesis: Therapeutic Implications
  New England Journal of Medicine, 1971